Opinion · 117th Congress
‘Rebate rule’ is wrong path to reducing prescription drug costs
The Government Accountability Office, in a 2019 report, reported that PBMs passed 99.6 percent — all but less than one-half of 1 percent — of rebates to Part D plan sponsors.